Follow-up After Endovascular Repair of Abdominal Aortic Aneurysm
NCT ID: NCT00488943
Last Updated: 2023-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2005-01-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endovascular Exclusion of Thoracoabdominal And/or Paravisceral Abdominal Aortic Aneurysm
NCT00483249
Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts
NCT01937949
Hemodynamic Changes After Aortic Aneurysm Treatment With Stent-Graft
NCT00488358
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts
NCT00583050
Endovascular Repair of Abdominal Aortic Aneurysms
NCT00803075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AAA Endovascular Bifurcated Stent-Graft
Treatment of Abdominal Aortic Aneurysm with a Zenith Endovascular Bifurcated Stent-Graft.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treatment of AAA with Zenith Stent-Graft
Exclusion Criteria
* Life expectancy less than two years
* Less than 18 years of age
* Unwilling to comply with clinical follow-up schedule
* Inability or refusal to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy AM Chuter, MD
Role: PRINCIPAL_INVESTIGATOR
Professor of Surgery
Joseph H Rapp, MD
Role: PRINCIPAL_INVESTIGATOR
Professor of Surgery
Linda M Reilly, MD
Role: PRINCIPAL_INVESTIGATOR
Professor of Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Vascular Surgery, SFVAMC
San Francisco, California, United States
Division of Vascular Surgery, UCSF
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shelley Dwyer, RN
Role: primary
Diana Kim, MPH
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Lee WA, Carter JW, Upchurch G, Seeger JM, Huber TS. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg. 2004 Mar;39(3):491-6. doi: 10.1016/j.jvs.2003.12.001.
Jacobs TS, Won J, Gravereaux EC, Faries PL, Morrissey N, Teodorescu VJ, Hollier LH, Marin ML. Mechanical failure of prosthetic human implants: a 10-year experience with aortic stent graft devices. J Vasc Surg. 2003 Jan;37(1):16-26. doi: 10.1067/mva.2003.58.
Beebe HG, Cronenwett JL, Katzen BT, Brewster DC, Green RM; Vanguard Endograft Trial Investigators. Results of an aortic endograft trial: impact of device failure beyond 12 months. J Vasc Surg. 2001 Feb;33(2 Suppl):S55-63. doi: 10.1067/mva.2001.111663.
Bertges DJ, Chow K, Wyers MC, Landsittel D, Frydrych AV, Stavropoulos W, Tan WA, Rhee RY, Fillinger MF, Fairman RM, Makaroun MS. Abdominal aortic aneurysm size regression after endovascular repair is endograft dependent. J Vasc Surg. 2003 Apr;37(4):716-23. doi: 10.1067/mva.2003.212.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H53537-26003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.